Results 201 to 210 of about 34,934 (250)
Diabetes, Obesity and Metabolism, EarlyView.ABSTRACT Background Artificial intelligence is emerging in healthcare systems. In type 1 diabetes, AI‐enabled tools are increasingly used to support nutrition assessment and insulin decision‐making, yet their clinical utility and safety remain unclear. Methods The study aims to identify and map the evidence on the clinical utility of AI‐based diabetes ...
Yucen Wu +4 more
wiley +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Journal of the American College of Surgeons, 2001
Diabetes and its complications are a significant cause of morbidity and mortality in the world. Patients with diabetes have an excess risk of mortality compared with the nondiabetic population. Mortality rates are 41.8% for the diabetic population and 10.1% for the nondiabetic population. Among the diabetic population, the most common cause of death is
K, Hanazaki, Y, Nosé, F C, Brunicardi
openaire +2 more sources
Diabetes and its complications are a significant cause of morbidity and mortality in the world. Patients with diabetes have an excess risk of mortality compared with the nondiabetic population. Mortality rates are 41.8% for the diabetic population and 10.1% for the nondiabetic population. Among the diabetic population, the most common cause of death is
K, Hanazaki, Y, Nosé, F C, Brunicardi
openaire +2 more sources
Artificial Cells, Blood Substitutes, and Biotechnology, 2003
In type 1 diabetes an absolute deficiency of insulin secretion requires exogenous insulin supply to guarantee the patient's life avoiding ketoacidotic coma and to prevent the chronic complications of diabetes. In order to obtain a more physiological replacement therapy different approaches have been pursued since the early 70s to create an artificial ...
Paolo, Brunetti +2 more
openaire +2 more sources
In type 1 diabetes an absolute deficiency of insulin secretion requires exogenous insulin supply to guarantee the patient's life avoiding ketoacidotic coma and to prevent the chronic complications of diabetes. In order to obtain a more physiological replacement therapy different approaches have been pursued since the early 70s to create an artificial ...
Paolo, Brunetti +2 more
openaire +2 more sources
An Artificial Endocrine Pancreas
Diabetes, 1974In order to regulate the blood sugar in the intact depancreatized dog as precisely as that accomplished by its normal pancreas, specific equipment has been devised to deliver insulin or glucose continuously and establish normoglycemia both in the fasting and glucose-loaded states.
A M, Albisser +5 more
openaire +2 more sources
Nursing Standard, 2013
Before we talk about the artificial pancreas, we have to understand its structure and function. The pancreas, which is shown in Fig. 20.1, is located below the stomach and above the duodenum. It releases endocrine hormones (insulin, amylin, and glucagon) into the portal vein, where it flows directly to the liver.
openaire +2 more sources
Before we talk about the artificial pancreas, we have to understand its structure and function. The pancreas, which is shown in Fig. 20.1, is located below the stomach and above the duodenum. It releases endocrine hormones (insulin, amylin, and glucagon) into the portal vein, where it flows directly to the liver.
openaire +2 more sources
Artificial intelligence for natural product drug discovery
Nature Reviews Drug Discovery, 2023Michael W Mullowney +2 more
exaly